![Gliclazide Modified Release Tablets at Rs 1230/box | Gliclazide Diabetes Tablet in Nashik | ID: 23514689173 Gliclazide Modified Release Tablets at Rs 1230/box | Gliclazide Diabetes Tablet in Nashik | ID: 23514689173](https://5.imimg.com/data5/SELLER/Default/2021/6/SF/OH/YL/56908763/gliclazide-modified-release-tablets-500x500.jpg)
Gliclazide Modified Release Tablets at Rs 1230/box | Gliclazide Diabetes Tablet in Nashik | ID: 23514689173
![Various Modified Tablets | Sustained release tablet | Multilayered tablets | Pharmaceutics DPharm1st - YouTube Various Modified Tablets | Sustained release tablet | Multilayered tablets | Pharmaceutics DPharm1st - YouTube](https://i.ytimg.com/vi/vFgPCsNcWuI/sddefault.jpg)
Various Modified Tablets | Sustained release tablet | Multilayered tablets | Pharmaceutics DPharm1st - YouTube
![Doxofylline Modified Release Tablets at Rs 1250/box | Pharmaceutical Tablet in Hapur | ID: 23871204291 Doxofylline Modified Release Tablets at Rs 1250/box | Pharmaceutical Tablet in Hapur | ID: 23871204291](https://5.imimg.com/data5/SELLER/Default/2021/9/VY/XA/WI/5411298/doxofylline-modified-release-tablet-500x500.jpg)
Doxofylline Modified Release Tablets at Rs 1250/box | Pharmaceutical Tablet in Hapur | ID: 23871204291
![Trimzed Allopathic Trimetazidine Dihydrochloride Modified Release Tablets 60mg at Rs 200/strip in New Delhi Trimzed Allopathic Trimetazidine Dihydrochloride Modified Release Tablets 60mg at Rs 200/strip in New Delhi](https://5.imimg.com/data5/SELLER/Default/2022/2/FO/RK/HI/13166357/trimetazidine-dihydrochloride-modified-release-tablets-60mg-500x500.jpg)
Trimzed Allopathic Trimetazidine Dihydrochloride Modified Release Tablets 60mg at Rs 200/strip in New Delhi
![Octasa 400 mg Modified Release Tablets (Active substance: mesalazine) used to treat mild to moderate attacks of ulcerative colitis Stock Photo - Alamy Octasa 400 mg Modified Release Tablets (Active substance: mesalazine) used to treat mild to moderate attacks of ulcerative colitis Stock Photo - Alamy](https://c8.alamy.com/comp/WPHK7W/octasa-400-mg-modified-release-tablets-active-substance-mesalazine-used-to-treat-mild-to-moderate-attacks-of-ulcerative-colitis-WPHK7W.jpg)
Octasa 400 mg Modified Release Tablets (Active substance: mesalazine) used to treat mild to moderate attacks of ulcerative colitis Stock Photo - Alamy
![Advances in mechanistic understanding of release rate control mechanisms of extended-release hydrophilic matrix tablets | Therapeutic Delivery Advances in mechanistic understanding of release rate control mechanisms of extended-release hydrophilic matrix tablets | Therapeutic Delivery](https://www.future-science.com/cms/10.4155/tde-2016-0026/asset/images/medium/figure1.gif)
Advances in mechanistic understanding of release rate control mechanisms of extended-release hydrophilic matrix tablets | Therapeutic Delivery
![Modified and sustained release technologies: Sustained release tablets (Matrix, Gastric retentive formulation) | SPERA PHARMA, Inc. Modified and sustained release technologies: Sustained release tablets (Matrix, Gastric retentive formulation) | SPERA PHARMA, Inc.](https://www.spera-pharma.co.jp/wp-content/uploads/2019/02/formulation03en.jpg)